CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company ...
All Prior Investors Exercise Pro-rata Rights, Highlights Fintech and Healthcare Industries’ Need for Private Data Sharing and Collaboration TripleBlind ...
DENVER, Feb. 19, 2021 (GLOBE NEWSWIRE) -- Nexien BioPharma, Inc. ("Nexien"or the"Company") (OTCQB:NXEN), a next generation biopharmaceutical company focused ...
Fort Collins, CO., Feb. 11, 2021 /PRNewswire/ -- Cytocom, Inc., a leading biopharmaceutical company creating second generation immune therapies, ...
Press Release 8 December 2020 Immunicum AB (publ) Provides Additional Information on the Proposed Transaction and Virtual Investor Event ...
SUWANEE, Ga., Nov. 13, 2020 (GLOBE NEWSWIRE) -- Digirad Corporation (Nasdaq: DRAD; DRADP) (“Digirad” or the “Company”), a diversified ...
FRAMINGHAM, Mass., Oct. 22, 2020 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB:ARTH) (“Arch” or the “Company”), developer of novel ...
Vancouver, Canada and Delft, Netherlands, Oct. 20, 2020 (GLOBE NEWSWIRE) -- Chrysalix Venture Capital, a global venture capital fund ...
SANTA BARBARA, Calif.--(BUSINESS WIRE)--QAD Inc. (Nasdaq: QADA) (Nasdaq: QADB), a leading provider of flexible, cloud-based enterprise software and services ...
LEESBURG, VA / ACCESSWIRE / August 21, 2020 / Quantum Computing Inc. (OTCQB:QUBT) (QCI), a technology leader in quantum-ready ...
